Joshua N Farr1,2,3, Japneet Kaur4,5, Madison L Doolittle4,5, Sundeep Khosla4,5. 1. Division of Endocrinology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, 55905, USA. farr.joshua@mayo.edu. 2. Robert and Arlene Kogod Center on Aging, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, 55905, USA. farr.joshua@mayo.edu. 3. Division of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, 55905, USA. farr.joshua@mayo.edu. 4. Division of Endocrinology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, 55905, USA. 5. Robert and Arlene Kogod Center on Aging, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, 55905, USA.
Abstract
PURPOSE OF REVIEW: Senescent cells are now known to accumulate in multiple tissues with aging and through their inflammation (the senescence-associated secretory phenotype, SASP) contribute to aging and chronic diseases. Here, we review the roles of senescent osteocytes in the context of bone loss. RECENT FINDINGS: Numerous studies have established that senescent osteocytes accumulate in the bone microenvironment with aging in mice and in humans. Moreover, at least in mice, elimination of senescent cells results in attenuation of age-related bone loss. Osteocyte senescence also occurs in response to other cellular stressors, including radiotherapy, chemotherapy, and metabolic dysfunction, where it appears to mediate skeletal deterioration. Osteocyte senescence is linked to bone loss associated with aging and other conditions. Senescent osteocytes are potential therapeutic targets to alleviate skeletal dysfunction. Additional studies better defining the underlying mechanisms as well as translating these exciting findings from mouse models to humans are needed.
PURPOSE OF REVIEW: Senescent cells are now known to accumulate in multiple tissues with aging and through their inflammation (the senescence-associated secretory phenotype, SASP) contribute to aging and chronic diseases. Here, we review the roles of senescent osteocytes in the context of bone loss. RECENT FINDINGS: Numerous studies have established that senescent osteocytes accumulate in the bone microenvironment with aging in mice and in humans. Moreover, at least in mice, elimination of senescent cells results in attenuation of age-related bone loss. Osteocyte senescence also occurs in response to other cellular stressors, including radiotherapy, chemotherapy, and metabolic dysfunction, where it appears to mediate skeletal deterioration. Osteocyte senescence is linked to bone loss associated with aging and other conditions. Senescent osteocytes are potential therapeutic targets to alleviate skeletal dysfunction. Additional studies better defining the underlying mechanisms as well as translating these exciting findings from mouse models to humans are needed.
Entities:
Keywords:
Aging; Chemotherapy; Osteocyte; Radiotherapy; Senescence; Type 2 diabetes mellitus
Authors: Cristina Aguayo-Mazzucato; Joshua Andle; Terrence B Lee; Ayush Midha; Lindsay Talemal; Vaja Chipashvili; Jennifer Hollister-Lock; Jan van Deursen; Gordon Weir; Susan Bonner-Weir Journal: Cell Metab Date: 2019-05-30 Impact factor: 27.287
Authors: Denise E Bonds; Joseph C Larson; Ann V Schwartz; Elsa S Strotmeyer; John Robbins; Beatriz L Rodriguez; Karen C Johnson; Karen L Margolis Journal: J Clin Endocrinol Metab Date: 2006-06-27 Impact factor: 5.958
Authors: Brittany A Eckhardt; Jennifer L Rowsey; Brianne S Thicke; Daniel G Fraser; Katherine L O'Grady; Olga P Bondar; Jolaine M Hines; Ravinder J Singh; Andrew R Thoreson; Kuntol Rakshit; Anthony B Lagnado; João F Passos; Adrian Vella; Aleksey V Matveyenko; Sundeep Khosla; David G Monroe; Joshua N Farr Journal: JCI Insight Date: 2020-05-07
Authors: Yi Zhu; Tamara Tchkonia; Tamar Pirtskhalava; Adam C Gower; Husheng Ding; Nino Giorgadze; Allyson K Palmer; Yuji Ikeno; Gene B Hubbard; Marc Lenburg; Steven P O'Hara; Nicholas F LaRusso; Jordan D Miller; Carolyn M Roos; Grace C Verzosa; Nathan K LeBrasseur; Jonathan D Wren; Joshua N Farr; Sundeep Khosla; Michael B Stout; Sara J McGowan; Heike Fuhrmann-Stroissnigg; Aditi U Gurkar; Jing Zhao; Debora Colangelo; Akaitz Dorronsoro; Yuan Yuan Ling; Amira S Barghouthy; Diana C Navarro; Tokio Sano; Paul D Robbins; Laura J Niedernhofer; James L Kirkland Journal: Aging Cell Date: 2015-04-22 Impact factor: 9.304
Authors: Mikolaj Ogrodnik; Satomi Miwa; Tamar Tchkonia; Dina Tiniakos; Caroline L Wilson; Albert Lahat; Christoper P Day; Alastair Burt; Allyson Palmer; Quentin M Anstee; Sushma Nagaraja Grellscheid; Jan H J Hoeijmakers; Sander Barnhoorn; Derek A Mann; Thomas G Bird; Wilbert P Vermeij; James L Kirkland; João F Passos; Thomas von Zglinicki; Diana Jurk Journal: Nat Commun Date: 2017-06-13 Impact factor: 14.919
Authors: Tyler J Bussian; Asef Aziz; Charlton F Meyer; Barbara L Swenson; Jan M van Deursen; Darren J Baker Journal: Nature Date: 2018-09-19 Impact factor: 49.962
Authors: Matthew J Yousefzadeh; Yi Zhu; Sara J McGowan; Luise Angelini; Heike Fuhrmann-Stroissnigg; Ming Xu; Yuan Yuan Ling; Kendra I Melos; Tamar Pirtskhalava; Christina L Inman; Collin McGuckian; Erin A Wade; Jonathon I Kato; Diego Grassi; Mark Wentworth; Christin E Burd; Edgar A Arriaga; Warren L Ladiges; Tamara Tchkonia; James L Kirkland; Paul D Robbins; Laura J Niedernhofer Journal: EBioMedicine Date: 2018-09-29 Impact factor: 8.143